Quick Answer
Catheter Precision, Inc. reported Total Revenue of $819.0 thousand for fiscal year 2025.
Catheter Precision, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $819.0K +95.0% |
$420.0K -5.0% |
$442.0K +3057.1% |
$14.0K -36.4% |
$22.0K -91.5% |
$259.0K -96.4% |
| Revenue (ASC 606) | $819.0K +95.0% |
$420.0K -5.0% |
$442.0K +3057.1% |
$14.0K -36.4% |
$22.0K -91.5% |
$259.0K -96.4% |
| Net Income | -$17.18M -3.2% |
-$16.64M +76.4% |
-$70.57M -162.7% |
-$26.86M -7.2% |
-$25.07M +30.4% |
-$36.05M +36.7% |
| Diluted EPS | — | — | — | -$25.98 +89.5% |
-$248.22 | — |
| Total Assets | $15.86M -42.9% |
$27.77M -9.6% |
$30.74M +82.6% |
$16.84M -20.0% |
$21.04M -37.1% |
$33.44M -24.1% |
| Cash and Equivalents | $88.0K -96.9% |
$2.87M -19.4% |
$3.56M -77.5% |
$15.86M +5.4% |
$15.04M -37.1% |
$23.91M +63.9% |
| Stockholders Equity | $7.05M -40.0% |
$11.76M -44.5% |
$21.19M +128.9% |
$9.26M -32.3% |
$13.67M -35.3% |
$21.15M -36.2% |
| R&D Expense | — | $272.0K -42.7% |
$475.0K -92.6% |
$6.39M -47.8% |
$12.25M +36.8% |
$8.96M +97.7% |
| Operating Income | -$21.14M -88.1% |
-$11.24M +85.6% |
-$78.12M -189.7% |
-$26.96M +7.9% |
-$29.27M +17.3% |
-$35.40M +38.7% |
| Gross Profit | $756.0K +100.0% |
$378.0K -8.3% |
$412.0K +380.3% |
-$147.0K +90.4% |
-$1.54M +19.6% |
-$1.91M -15.9% |
| Shares Outstanding | 1.74M +312.8% |
421,296 -40.0% |
702,662 -49.8% |
1.40M +900.0% |
140,000 -99.8% |
73.00M +13153.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $226.0K | +135.4% | +6.6% |
| Revenue (ASC 606) | September 30, 2025 | $226.0K | +135.4% | +6.6% |
| Net Income | September 30, 2025 | -$2.25M | +45.4% | +55.9% |
| Diluted EPS | September 30, 2022 | -$4.36 | +87.0% | -1576.9% |
| Total Assets | September 30, 2025 | $25.47M | -4.8% | -0.4% |
| Cash and Equivalents | September 30, 2025 | $1.07M | -15.2% | +28.3% |
| Stockholders Equity | September 30, 2025 | $6.78M | -47.1% | -0.1% |
| R&D Expense | September 30, 2024 | $63.0K | -43.8% | -22.2% |
| Operating Income | September 30, 2025 | -$3.02M | -5.7% | +35.5% |
| Gross Profit | September 30, 2025 | $208.0K | +141.9% | +5.1% |
| Shares Outstanding | September 30, 2025 | 1.65M | -52.3% | -91.3% |
- Catheter Precision, Inc. reported Total Revenue of $819.0 thousand for fiscal year 2025.
- Catheter Precision, Inc. showed an increase of +95.0% in Total Revenue compared to the prior fiscal year.
- Catheter Precision, Inc. reported Revenue (ASC 606) of $819.0 thousand for fiscal year 2025.
- Catheter Precision, Inc. showed an increase of +95.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Catheter Precision, Inc. reported Net Income of -$17.18 million for fiscal year 2025.
- Catheter Precision, Inc. showed a decrease of -3.2% in Net Income compared to the prior fiscal year.
- Catheter Precision, Inc. reported Diluted EPS of $25.98 per share (loss) for fiscal year 2022.
- Catheter Precision, Inc. showed an increase of +89.5% in Diluted EPS compared to the prior fiscal year.
- Catheter Precision, Inc. reported Total Assets of $15.86 million for fiscal year 2025.
- Catheter Precision, Inc. showed a decrease of -42.9% in Total Assets compared to the prior fiscal year.
- Catheter Precision, Inc. reported Cash and Equivalents of $88.0 thousand for fiscal year 2025.
- Catheter Precision, Inc. showed a decrease of -96.9% in Cash and Equivalents compared to the prior fiscal year.
- Catheter Precision, Inc. reported Stockholders Equity of $7.05 million for fiscal year 2025.
- Catheter Precision, Inc. showed a decrease of -40.0% in Stockholders Equity compared to the prior fiscal year.
- Catheter Precision, Inc. reported R&D Expense of $272.0 thousand for fiscal year 2024.
- Catheter Precision, Inc. showed a decrease of -42.7% in R&D Expense compared to the prior fiscal year.
- Catheter Precision, Inc. reported Operating Income of -$21.14 million for fiscal year 2025.
- Catheter Precision, Inc. showed a decrease of -88.1% in Operating Income compared to the prior fiscal year.
- Catheter Precision, Inc. reported Gross Profit of $756.0 thousand for fiscal year 2025.
- Catheter Precision, Inc. showed an increase of +100.0% in Gross Profit compared to the prior fiscal year.
- Catheter Precision, Inc. reported Shares Outstanding of 1.74 million shares for fiscal year 2025.
- Catheter Precision, Inc. showed an increase of +312.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: